Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2005-07-26
2005-07-26
Russel, Jeffrey Edwin (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S324000
Reexamination Certificate
active
06921750
ABSTRACT:
The present invention is directed to peptide analogues of fragment of parathyroid hormone (PTH) or parathyroid hormone-related protein (PTHrP), a method of using said analogues alone or in combination with a bisphosphonate or calcitonin to treat osteoporosis and pharmaceutical compositions comprising said analogues alone or in combination with a bisphosphonate or calcitonin.
REFERENCES:
patent: 4656250 (1987-04-01), Morita et al.
patent: 5434246 (1995-07-01), Fukuda et al.
patent: 5455329 (1995-10-01), Wingender et al.
patent: 5457047 (1995-10-01), Wingender et al.
patent: 5589452 (1996-12-01), Krstenansky et al.
patent: 5599792 (1997-02-01), Kronis et al.
patent: 5723577 (1998-03-01), Dong
patent: 5955574 (1999-09-01), Dong
patent: 5969095 (1999-10-01), Dong
patent: 6544949 (2003-04-01), Dong
patent: 64834/96 (1999-07-01), None
patent: 0 293 158 (1988-11-01), None
patent: 451867 (1991-10-01), None
patent: 0 561 412 (1993-09-01), None
patent: 748817 (1996-12-01), None
patent: 2269176 (1994-02-01), None
patent: P9500110 (1995-06-01), None
patent: P9500115 (1995-06-01), None
patent: 217 843 (1995-09-01), None
patent: WO 90/10067 (1990-09-01), None
patent: WO 93/06846 (1993-04-01), None
patent: 94/01460 (1994-01-01), None
patent: 94/02510 (1994-02-01), None
patent: WO95/02610 (1995-01-01), None
patent: 95/04752 (1995-02-01), None
patent: 96/19246 (1996-06-01), None
patent: 96/40775 (1996-12-01), None
patent: 97/02834 (1997-01-01), None
Chorev et al., “Modifications of Position 12 in Parathyroid Hormone . . . ”, Bochemistry, vol. 29, No. 6, pp. 1580-1586 (1990).
Lynn H. Caporale et al.; “Characterization of parathyroid hormone antagonists” Peptides, Chemistry and Biology; Proceedings of the Tenth American Peptide Symposium; (1987); pp. 449-451.
Horiuchi N. et al.; “Similarity of synthetic peptide from human tumor to parathyroid hormone in vivo and in vitro” Science; (1987); vol. 238 pp. 1566-1568.
Gardella, T.J. et al.; “Parathyroid Hormone (PTH)-PTH-Related Peptide Hybrid Peptides Reveal Functional Interactions Between The 1-14 and 15 34 Domains of the Ligand”; J. Biol. Chem., vol. 270, No 12, pp 6584-6588, (1995).
Barden et al.,; “NMR Solution Structure of Human Parathyroid Hormone (1-34)”; Biochemistry 32:7126-7132; (1993).
Cohen et al.; “Analogues of Parathyroid Hormone Modified at Positions 3 and 6”; The Journal of Biological Chemistry 266:No. 3;1997-2004; (1991).
Karle et al.; “Structural Characteristics of α-Helical Peptide Molecules Containing Aib Residues”; Biochemistry 29:No. 29;6747-6756; (1990).
Leaffer et al.; Modulation of Osteogenic Cell Ultrastructure by RS-23581; an Analog of Human Parathyroid Hormone (PTH)-Related Peptide-(1-34), and Bovine PTH-(1-34); Endocrinology 136:No. 8;3624-3631, (1995).
Li et al.; “A Measure of Helical Propensity for Amino Acids in Membrane Environments”; Structural Biology 1:No. 6;368-373; (1994).
McLean et al.; “Minimal Peptide Length for Interaction of Amphipathic α-Helical Peptides with Phosphatidylcholine Liposomes”; Biochemistry 30:31-37; (1991).
Neugebauer et al.; “Structural Elements of Human Parathyroid Hormone and Their Possible Relation to Biological Activities”; Biochemistry 31:2056-2063; (1992).
Strickland et al.; “Structure of Human Parathyroid Hormone (1-34) in the Presence of Solvents and Micelles”; Biochemistry 32:6050-6057; (1993).
Surewicz et al.; “Structure-function Relationships in Human Parathyriod Hormone: The Essential Role of Amphiphilic α-Helix”; Peptide Hormone: 556-558 (not dated).
Feeney Alan F.
Fish & Richardson
Morrill Brian R.
Russel Jeffrey Edwin
Societe de Conseils de Recherches et d'Applications Scientifique
LandOfFree
Analogs of parathyroid hormone does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Analogs of parathyroid hormone, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Analogs of parathyroid hormone will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3418659